XML 85 R5.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Statements of Changes in Members’ and Stockholders’ Equity (Deficit) (Unaudited) - USD ($)
Members’ Contribution
Preferred Units
Common Stock
Class A
Common Stock
Class B
Subscription Receivable
Additional Paid-In Capital
Retained Earnings (Accumulated Deficit)
Total
Balance at Dec. 31, 2022 $ 2,047,872 $ 8,902,226   $ (5,788,985) $ 5,161,113
Balance (in Shares) at Dec. 31, 2022              
Retroactive application of recapitalization (2,047,872) (8,902,226) $ 3,255 $ 476   10,946,367
Retroactive application of recapitalization (in Shares)     32,547,718 4,759,642        
Balance at Jan. 01, 2023 $ 3,255 $ 476   10,946,367 (5,788,985) 5,161,113
Balance (in Shares) at Jan. 01, 2023     32,547,718 4,759,642        
Balance at Dec. 31, 2022 2,047,872 8,902,226   (5,788,985) 5,161,113
Balance (in Shares) at Dec. 31, 2022              
Issuance of common stock $ 11   255,850 255,861
Issuance of common stock (in Shares)     105,331        
Net income, (Loss) as restated               (834,627)
Balance at Mar. 31, 2023 $ 3,266 $ 476   11,202,217 (6,623,612) 4,582,347
Balance (in Shares) at Mar. 31, 2023     32,653,049 4,759,642        
Balance at Dec. 31, 2022 2,047,872 8,902,226   (5,788,985) 5,161,113
Balance (in Shares) at Dec. 31, 2022              
Net income, (Loss) as restated   (834,627) (834,627)
Balance at Dec. 31, 2023 2,109,310 9,158,087 (17,168,101) (5,900,704)
Balance (in Shares) at Dec. 31, 2023            
Retroactive application of recapitalization (2,109,310) (9,158,087) $ 3,274 $ 476 11,263,647
Retroactive application of recapitalization (in Shares)     32,731,583 4,759,642        
Balance at Jan. 01, 2024 $ 3,274 $ 476 11,263,647 (17,168,101) (5,900,704)
Balance (in Shares) at Jan. 01, 2024     32,731,583 4,759,642        
Balance at Dec. 31, 2023 2,109,310 9,158,087 (17,168,101) (5,900,704)
Balance (in Shares) at Dec. 31, 2023            
Issuance of common stock $ 581 (6,000,000) 49,364,419 $ 43,365,000
Issuance of common stock (in Shares)     5,807,647       5,807,647
Exercise of warrants $ 38 45,722 $ 45,760
Exercise of warrants (in Shares)     380,771        
Exercise of options $ 214 56,036 56,250
Exercise of options (in Shares)     2,141,839        
Reverse capitalization, net of transaction costs $ 800 (21,028,277)   (21,027,477)
Reverse capitalization, net of transaction costs (in Shares)     8,001,930        
Net income, (Loss) as restated 181,555,292 181,555,292
Balance at Mar. 31, 2024 $ 4,907 $ 476 $ (6,000,000) $ 39,701,547 $ 164,387,191 $ 198,094,121
Balance (in Shares) at Mar. 31, 2024     49,063,770 4,759,642